This week on The Necessary Conversation, Chad, Haley, and Mary Lou discuss the biggest topics in politics. 💊 News broke that the FDA's "compassionate use" program — reserved for patients with serious or life-threatening conditions — was used to give a single 79-year-old man access to an unapproved experimental drug called Retatrutide. Trump was 79 when the request was made. The drug treats obesity, sleep apnea, and pulmonary hypertension — conditions that can be fatal in combination. The Whit...